Screening of novel and selective inhibitors for neuronal nitric oxide synthase (nNOS) via structure-based drug design techniques
Authors:
- 24 March 2022
- journal article
- research article
- Published by Taylor & Francis in Journal of Biomolecular Structure and Dynamics
- Vol. 41 (8) , 3607-3629
Abstract
NO, or nitric oxide, is produced by a family of enzymes called nitric oxide synthase (NOS) from L-arginine. NO regulates many physiological functions such as smooth muscle relaxation, immune defense, and memory function. The overproduction of NO by the neuronal isoform of nitric oxide synthase (nNOS) is implicated in neurodegeneration and neuropathic pain, making nNOS inhibition a promising therapeutic approach. Many developed nNOS inhibitors, generally L-arginine mimetics, have some issues in selectivity and bioavailability. According to earlier studies, targeting nNOS has the advantage of decreasing excess NO in the brain while avoiding the negative consequences of inhibiting the two isozymes: endothelial NOS (eNOS) and inducible NOS (iNOS). This study applied structure-based virtual screening, molecular docking, and molecular dynamics simulations to design potent and selective inhibitors against nNOS over related isoforms (eNOS and iNOS) using human X-ray crystal structures of the NOS isoforms. It was discovered that some compounds displayed a very good inhibitory potency for hnNOS and moderate selectivity for the other isozymes, eNOS and iNOS, in addition to good solubility and desirable physiochemical properties. The compounds which showed good stability and selectivity with nNOS, such as ZINC000013485422, can be interesting and informative guidance for designing more potent human nNOS inhibitors. Communicated by Ramaswamy H. SarmaKeywords
This publication has 82 references indexed in Scilit:
- GalaxyWEB server for protein structure prediction and refinementNucleic Acids Research, 2012
- Nitric oxide synthases: regulation and functionEuropean Heart Journal, 2011
- Computational ligand-based rational design: role of conformational sampling and force fields in model developmentMedChemComm, 2011
- Regulation of nitric oxide production in health and diseaseCurrent Opinion in Clinical Nutrition and Metabolic Care, 2010
- AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreadingJournal of Computational Chemistry, 2009
- Selective neuronal nitric oxide synthase inhibitors and the prevention of cerebral palsyAnnals of Neurology, 2009
- Anchored plasticity opens doors for selective inhibitor design in nitric oxide synthaseNature Chemical Biology, 2008
- In silico pharmacology for drug discovery: methods for virtual ligand screening and profilingBritish Journal of Pharmacology, 2007
- Nitric Oxide and Peroxynitrite in Health and DiseasePhysiological Reviews, 2007
- Scalable molecular dynamics with NAMDJournal of Computational Chemistry, 2005